| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0065-3519(97)80006-7 |
| P698 | PubMed publication ID | 9395731 |
| P2093 | author name string | J Walter | |
| K A High | |||
| P2860 | cites work | Site-specific integration by adeno-associated virus | Q24558738 |
| Structure of human factor VIII | Q28630991 | ||
| Nucleotide sequence of the gene for human factor IX (antihemophilic factor B) | Q28646323 | ||
| An alternative approach to somatic cell gene therapy | Q33571138 | ||
| Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs | Q33671665 | ||
| Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B. | Q33739384 | ||
| Canine hemophilia B resulting from a point mutation with unusual consequences | Q34326780 | ||
| A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia | Q34417597 | ||
| Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression | Q34615481 | ||
| Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice | Q34675871 | ||
| In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs | Q35109095 | ||
| Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo | Q35123124 | ||
| Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy | Q35232341 | ||
| In vivo production of human factor VII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery | Q35387018 | ||
| Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver | Q35559973 | ||
| Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer | Q36231835 | ||
| Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector | Q36663364 | ||
| Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants | Q36893013 | ||
| Expression of human factor IX in mice after injection of genetically modified myoblasts | Q36950396 | ||
| High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. | Q37093747 | ||
| Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo | Q37300317 | ||
| Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B | Q37594306 | ||
| Successful expression of human factor IX following repeat administration of adenoviral vector in mice. | Q37685172 | ||
| Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene | Q40506896 | ||
| An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes | Q40655841 | ||
| Gene therapy: adenovirus vectors. | Q40835892 | ||
| Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes | Q41484655 | ||
| In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs | Q41524708 | ||
| Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions | Q41771926 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate | Q45846717 | ||
| Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease | Q45864427 | ||
| Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration | Q45866667 | ||
| Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. | Q45867442 | ||
| Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A | Q45868121 | ||
| Characterization of the human factor VIII gene | Q48385931 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 119-34 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Advances in veterinary medicine | Q27714281 |
| P1476 | title | Gene therapy for the hemophilias | |
| P478 | volume | 40 |
| Q34777289 | Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. | cites work | P2860 |
Search more.